Catalent’s Optiform® Solution Suite platform integrates four technologies to match the best drug delivery methodologies to developmental API molecules, with the goal of providing optimal animal PK prototypes in just twelve weeks.
Catalent’s new OptiForm Solution Suite combines both predictive and high throughput screening platforms - designed to identify the most stable and efficient drug form of an API - with delivery technology feasibility studies, and expert input from multi-disciplinary teams to address key developmental challenges.
OptiForm Solution Suite is designed to efficiently and rapidly help solve complex bioavailability challenges for early stage molecules by integrating superior expertise and know-how to match the best, most innovative, drug delivery technologies to each developmental molecule, with the goal of providing optimal animal PK materials in just twelve weeks.
OptiForm Solution Suite helps enable faster development with a 3-step process:
Contact Details :
Catalent Pharma Solutions
Website: www.catalent.com
E-mail: solutions@catalent.com
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.